Pieris Pharmaceuticals To Present at Evercore ISI Healthconx Conference

Rhea-AI Summary

Pieris Pharmaceuticals (NASDAQ:PIRS) announced its management presentation at the Evercore ISI HealthCONx Conference on December 1, 2022, at 12:10 PM ET. The conference will focus on the company’s innovative biotherapeutics developed through its proprietary Anticalin technology platform for treating respiratory diseases and cancer. Investors and interested parties can access the presentation via a webcast. Pieris Pharmaceuticals specializes in creating inhalable Anticalin proteins and locally-activated bispecifics, aimed at improving clinical outcomes in patients.

BOSTON, MA / ACCESSWIRE / November 23, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that management is scheduled to present at the Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 12:10 PM ET. A webcast of the company's presentation will be available at this link.

About Pieris Pharmaceuticals:

Pieris is a clinical-stage biotechnology company that combines leading protein engineering capabilities and deep understanding into molecular drivers of disease to develop medicines that drive local biology to produce superior clinical outcomes for patients. Our pipeline includes inhalable Anticalin proteins to treat respiratory diseases and locally-activated bispecifics for immuno-oncology. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by respiratory and immuno-oncology focused partnerships with leading pharmaceutical companies. For more information, visit www.pieris.com.

Investor Relations Contact:
Pieris Pharmaceuticals, Inc.
Maria Kelman
Executive Director, Investor Relations
+1 857 362 9635
kelman@pieris.com

SOURCE: Pieris Pharmaceuticals, Inc.

View source version on accesswire.com:
https://www.accesswire.com/727939/Pieris-Pharmaceuticals-To-Present-at-Evercore-ISI-Healthconx-Conference

FAQ

When is Pieris Pharmaceuticals presenting at the Evercore ISI HealthCONx Conference?

Pieris Pharmaceuticals is scheduled to present on December 1, 2022, at 12:10 PM ET.

What technology does Pieris Pharmaceuticals use for its biotherapeutics?

Pieris Pharmaceuticals uses its proprietary Anticalin technology platform to develop novel biotherapeutics.

What types of diseases does Pieris Pharmaceuticals focus on?

Pieris Pharmaceuticals focuses on respiratory diseases, cancer, and other indications.

How can I access the Pieris Pharmaceuticals presentation?

The presentation can be accessed via a webcast available on their official link.

What is the stock symbol for Pieris Pharmaceuticals?

The stock symbol for Pieris Pharmaceuticals is PIRS.